{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:43:49Z","timestamp":1790905429018,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["K01-HG009173"],"award-info":[{"award-number":["K01-HG009173"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01-HD090019"],"award-info":[{"award-number":["R01-HD090019"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.gim.2023.100797","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T21:39:03Z","timestamp":1675114743000},"page":"100797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Benefits, harms, and costs of newborn genetic screening for hypertrophic cardiomyopathy: Estimates from the PreEMPT model"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4068-776X","authenticated-orcid":false,"given":"Kurt D.","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela M.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren N.","family":"Galbraith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha K.","family":"Stout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine Y.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn J.","family":"Hylind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Chen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gim.2023.100797_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13059-019-1626-2","article-title":"Where is genomics going next?","volume":"20","author":"Cheifet","year":"2019","journal-title":"Genome Biol"},{"key":"10.1016\/j.gim.2023.100797_bib2","doi-asserted-by":"crossref","first-page":"n2679","DOI":"10.1136\/bmj.n2679","article-title":"Should all babies have their genome sequenced at birth?","volume":"375","author":"Biesecker","year":"2021","journal-title":"BMJ"},{"issue":"25","key":"10.1016\/j.gim.2023.100797_bib3","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa1510687","article-title":"A\u00a0prospective study of sudden cardiac death among children and young adults","volume":"374","author":"Bagnall","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.gim.2023.100797_bib4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.gim.2023.100797_bib5","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.amjcard.2016.02.044","article-title":"Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States","volume":"117","author":"Maron","year":"2016","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.gim.2023.100797_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002460","article-title":"Evaluating the clinical validity of hypertrophic cardiomyopathy genes","volume":"12","author":"Ingles","year":"2019","journal-title":"Circ Genom Precis Med"},{"issue":"14","key":"10.1016\/j.gim.2023.100797_bib7","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2013.01.037","article-title":"Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy","volume":"61","author":"Maron","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.gim.2023.100797_bib9","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/s41436-021-01171-4","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2023.100797_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2018.12.027","article-title":"An age-based framework for evaluating genome-scale sequencing results in newborn screening","volume":"209","author":"Milko","year":"2019","journal-title":"J\u00a0Pediatr"},{"issue":"7","key":"10.1016\/j.gim.2023.100797_bib11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/gim.2016.193","article-title":"A\u00a0curated gene list for reporting results of newborn genomic sequencing","volume":"19","author":"Ceyhan-Birsoy","year":"2017","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.gim.2023.100797_bib12","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/CIRCGENETICS.115.001093","article-title":"Application of genetic testing in hypertrophic cardiomyopathy for preclinical disease detection","volume":"8","author":"Ingles","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"issue":"7","key":"10.1016\/j.gim.2023.100797_bib13","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/s41436-021-01124-x","article-title":"Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights","volume":"23","author":"Yeh","year":"2021","journal-title":"Genet Med"},{"issue":"10","key":"10.1016\/j.gim.2023.100797_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.29742","article-title":"Estimated cost-effectiveness of genetic testing in siblings of newborns with cancer susceptibility gene variants","volume":"4","author":"O\u2019Brien","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.gim.2023.100797_bib15","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/jnci\/djac013","article-title":"Population-based newborn screening for germline TP53 variants: clinical benefits, cost-effectiveness, and value of further research","volume":"114","author":"Kunst","year":"2022","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"Database issue","key":"10.1016\/j.gim.2023.100797_bib16","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"7809","key":"10.1016\/j.gim.2023.100797_bib17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.gim.2023.100797_bib18","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.gim.2023.100797_bib19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.106.621185","article-title":"Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry","volume":"115","author":"Colan","year":"2007","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.gim.2023.100797_bib20","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamacardio.2019.2861","article-title":"Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids)","volume":"4","author":"Norrish","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.gim.2023.100797_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.115.017633","article-title":"Hypertrophic cardiomyopathy in children, adolescents, and young adults associated with low cardiovascular mortality with contemporary management strategies","volume":"133","author":"Maron","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.gim.2023.100797_bib22","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.hrthm.2013.01.035","article-title":"The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011","volume":"10","author":"Kremers","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.gim.2023.100797_bib23","author":"Wilmoth"},{"issue":"1","key":"10.1016\/j.gim.2023.100797_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jamacardio.2019.4534","article-title":"Mortality among referral patients with hypertrophic cardiomyopathy vs the general European population","volume":"5","author":"Lorenzini","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.gim.2023.100797_bib25","first-page":"1813","article-title":"A\u00a0cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment","volume":"34","author":"Ostman-Smith","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gim.2023.100797_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2020.02.055","article-title":"Health economic evaluation of implantable cardioverter defibrillators in hypertrophic cardiomyopathy in adults","volume":"311","author":"Magnusson","year":"2020","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.gim.2023.100797_bib27","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s00246-013-0676-6","article-title":"Implanted defibrillators in young hypertrophic cardiomyopathy patients: a multicenter study","volume":"34","author":"Kamp","year":"2013","journal-title":"Pediatr Cardiol"},{"issue":"8","key":"10.1016\/j.gim.2023.100797_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/heartjnl-2011-300368","article-title":"A\u00a0cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy","volume":"98","author":"Ingles","year":"2012","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.gim.2023.100797_bib29","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2016.01.023","article-title":"Contemporary natural history and management of nonobstructive hypertrophic cardiomyopathy","volume":"67","author":"Maron","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.gim.2023.100797_bib30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.gim.2023.100797_bib31","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \u201cAll of Us\u201d research program","volume":"381","author":"Denny","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.gim.2023.100797_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026627","article-title":"Evaluating a custom-designed aid to improve communication of genetic results in families with hypertrophic cardiomyopathy: study protocol for a randomised controlled trial","volume":"9","author":"Burns","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.gim.2023.100797_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13073-020-00819-1","article-title":"Family history assessment significantly enhances delivery of precision medicine in the genomics era","volume":"13","author":"Bylstra","year":"2021","journal-title":"Genome Med"},{"issue":"7","key":"10.1016\/j.gim.2023.100797_bib34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/gim.2014.156","article-title":"The cost-effectiveness of returning incidental findings from next-generation genomic sequencing","volume":"17","author":"Bennette","year":"2015","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.gim.2023.100797_bib35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jval.2018.01.008","article-title":"Evaluating and valuing drugs for rare conditions: no easy answers","volume":"21","author":"Ollendorf","year":"2018","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.gim.2023.100797_bib36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40273-019-00873-7","article-title":"Review of valuation methods of preference-based measures of health for economic evaluation in child and adolescent populations: where are we now and where are we going?","volume":"38","author":"Rowen","year":"2020","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.gim.2023.100797_bib37","first-page":"365","article-title":"Prevention for those who can pay: insurance reimbursement of genetic-based preventive interventions in the liminal state between health and disease","volume":"2","author":"Prince","year":"2015","journal-title":"J\u00a0Law Biosci"},{"issue":"2","key":"10.1016\/j.gim.2023.100797_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/gim.2013.98","article-title":"Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary\u2019s Advisory Committee on Heritable Disorders in Newborns and Children","volume":"16","author":"Kemper","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2023.100797_bib39","article-title":"Principles and practice of screening for disease","author":"Wilson","year":"1968","journal-title":"Public Health Papers no. 34"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360023008109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360023008109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:55:55Z","timestamp":1761098155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360023008109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1098360023008109"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2023.100797","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benefits, harms, and costs of newborn genetic screening for hypertrophic cardiomyopathy: Estimates from the PreEMPT model","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2023.100797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Medical Genetics and Genomics. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100797"}}